<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Pro | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-16T23:26:12+08:00</updated>
  <subtitle>聚焦生物医药前沿，洞察研发投资风向</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>挑战三阴性乳腺癌！新型癌症疫苗：有效预防复发，100%小鼠存活 | Nature子刊</title>
    <updated>2020-11-16T21:02:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/JI_6n-sh7dl-kaTIzhVGYg</id>
    <link href="https://mp.weixin.qq.com/s/JI_6n-sh7dl-kaTIzhVGYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1抗体“新搭档”——iNK细胞疗法 | Science子刊最新成果</title>
    <updated>2020-11-15T20:59:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/ye5ksRw3Vq1oo8GULVpZWA</id>
    <link href="https://mp.weixin.qq.com/s/ye5ksRw3Vq1oo8GULVpZWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下一代癌症免疫疗法——CD25抗体 | Nature子刊最新成果</title>
    <updated>2020-11-14T21:00:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/Mep-kjJOqL_CQLJwkCXdPg</id>
    <link href="https://mp.weixin.qq.com/s/Mep-kjJOqL_CQLJwkCXdPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature最新报告：PD-1抗体“热门搭档”TOP20</title>
    <updated>2020-11-13T21:00:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/YbsR9rr8VaO1gBeT7lvJOg</id>
    <link href="https://mp.weixin.qq.com/s/YbsR9rr8VaO1gBeT7lvJOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature重要发现：PD-1抗体“新搭档”——PCSK9抑制剂</title>
    <updated>2020-11-12T20:59:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/npV4atBUiTHDffq4kOVmZw</id>
    <link href="https://mp.weixin.qq.com/s/npV4atBUiTHDffq4kOVmZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陆英明点评 | 基因疗法：眼部疾病治疗革新者</title>
    <updated>2020-11-11T21:03:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/RvVjC84VYbv3nMq7E38Wug</id>
    <link href="https://mp.weixin.qq.com/s/RvVjC84VYbv3nMq7E38Wug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>心脏损伤“救星”——胞外囊泡 | Science子刊封面论文</title>
    <updated>2020-11-10T21:00:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/k_4L4TVYMB7uEPkRadhcng</id>
    <link href="https://mp.weixin.qq.com/s/k_4L4TVYMB7uEPkRadhcng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Science关注：警惕基因疗法副作用，“天使综合征”临床试验被叫停</title>
    <updated>2020-11-09T20:46:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/zO5_zfKac-8f-lyHwAhodg</id>
    <link href="https://mp.weixin.qq.com/s/zO5_zfKac-8f-lyHwAhodg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞/BioNTech新冠疫苗III期研究成功：保护效力达90%</title>
    <updated>2020-11-09T20:46:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/hrvxvEMcydVZ2vJVGmxV-g</id>
    <link href="https://mp.weixin.qq.com/s/hrvxvEMcydVZ2vJVGmxV-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>青光眼新希望！基因疗法：有效再生神经元 | Nature子刊</title>
    <updated>2020-11-08T21:00:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/ykHCQ1yibwjWxTkG7XV7Lg</id>
    <link href="https://mp.weixin.qq.com/s/ykHCQ1yibwjWxTkG7XV7Lg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature：中国肿瘤药创新趋势</title>
    <updated>2020-11-08T21:00:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/M11EV_J257rRHr8czXlAGg</id>
    <link href="https://mp.weixin.qq.com/s/M11EV_J257rRHr8czXlAGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>挑战胰腺癌，新款ADC药物来了！</title>
    <updated>2020-11-07T21:00:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/cRI3DHzh6YSsByuTLxYGnA</id>
    <link href="https://mp.weixin.qq.com/s/cRI3DHzh6YSsByuTLxYGnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>